6PGD Upregulation is Associated with Chemo- and Immuno-Resistance of Renal Cell Carcinoma via AMPK Signaling-Dependent NADPH-Mediated Metabolic Reprograming

2020/06/20 by Jun Cao, Xiaosong Sun, Xuejun Zhang +1 · 7 citations
Biochemistry, Genetics and Molecular Biology · #Cancer, Hypoxia, and Metabolism #Biochemical and Molecular Research #Aldose Reductase and Taurine

paper · doi:10.1016/j.amjms.2020.06.014

Cited by

• Oxidative Pentose Phosphate Pathway Enzyme 6-Phosphogluconate Dehydrogenase Plays a Key Role in Breast Cancer Metabolism. [europepmc]
• Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies. [europepmc]
• Phosphogluconate dehydrogenase is a predictive biomarker for immunotherapy in hepatocellular carcinoma. [europepmc]
• Inhibition of 6-Phosphogluconate Dehydrogenase Reverses Epirubicin Resistance Through Metabolic Reprograming in Triple-Negative Breast Cancer Cells. [europepmc]
• The Cancer Antioxidant Regulation System in Therapeutic Resistance. [europepmc]
• Targeting the mevalonate pathway enhances the efficacy of 5-fluorouracil by regulating pyroptosis. [europepmc]
• Identification of telomere-related diagnostic markers in osteoarthritis based on bioinformatics analysis and machine learning. [europepmc]